Industry Insight
Discovery Technology
Analytical Laboratory Technology
Biopharma
Manufacturing
Delivery Systems
Ingredients, Formulation and Finishing
Bioprocessing
View our other publications with free access to extensive archives
  To view this article:
Existing subscribers please log in:
 
  USER NAME  
  PASSWORD  
   Or select

Or become a subscriber
 

Click here to view
our current issue



 
 

The Case for an Integrated IRT





Clinical trials hinge on patients having access to the supplies they need when they need them, and organisations often err so far on the side of caution they absorb exorbitant costs. Building a ‘just in case’ buffer of drugs can impact the return on investment (ROI) of any trial, and this is particularly true for expensive oncology investigational products and comparators.

However, it does not have to be this way. An integrated free picking (just-in-time) interactive response technology (IRT) interface can help companies reduce the costs of maintaining adequate buffers in their supply chain.

Bart Nicholson at Signant Health (July 2019)

Keywords: Manufacturing Signant Health CRF Bracket Free Picking IRT

    View full article    |    Back to Manufacturing section




Advair,Flovent,VentolinSymbicort,Serevent,FlonaseAstelin Rhinocort
IPT © 2021 Innovations in Pharmaceutical Technology | Terms and Conditions | caitlin@samedanltd.com | UK Contacts |
Providing a platform of communication on new ideas, developments and innovations | UK Tel No. +44 20 77243456 | Back to top of page |